Table: Garna Biosciences - 9-MTH group results

Carna Biosciences

07/11/2025 07:01

Nov 7 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Sep 30, 2025        Sep 30, 2024       Dec 31, 2025  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            395 mln             487 mln           722 mln     
                 (-18.8 pct)         (-31.5 pct)       (+13.5 pct)   
  Operating       loss 1.55           loss 1.58         loss 2.13    
  Recurring       loss 1.59           loss 1.58         loss 2.14    
  Net             loss 1.60           loss 1.59         loss 2.15    
  EPS          loss 83.76 yen      loss 90.52 yen    loss 112.46 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T